Transfer of Regulatory Approvals. At the Closing, Seller shall transfer the exclusive benefit of the Regulatory Approvals to Purchaser free of all Encumbrances, other than Permitted Encumbrances, on the terms and conditions set forth in this Section 6.10. As soon as practicable following the Closing Date but in any event no later than 20 days after the Closing Date, Seller shall make such notifications or filings with applicable Regulatory Authorities as may be necessary to effect the transfer of each of the Regulatory Approvals to Purchaser.
Transfer of Regulatory Approvals. (a) Promptly after the Closing Date (and in any event within five (5) business days after receiving written notice from Millennium under Section 3.1 of this Agreement) Schering shall provide each of Millennium and the New Commercial Licensee with appropriate documentation to grant each of them the right to access and cross-reference any applicable drug master file for the active pharmaceutical ingredient in the INTEGRILIN Products in each country in the Transferring Territory where Schering holds a Regulatory Approval, in the format required by the applicable Regulatory Authority, to enable each of Millennium and the New Commercial Licensee to perform each of their respective obligations under the New Commercial Agreement.
(b) During the Transition Period, Schering, Millennium and the New Commercial Licensee shall coordinate the Transfer of all Regulatory Approvals of INTEGRILIN Products in the Transferring Territory to the New Commercial Licensee, including, without limitation, the current [**] for the Transferring Territory. For purposes of clarity, it is anticipated that meetings with the Regulatory Authorities pursuant to Section 3.2(c) will include discussions with, and agreement of, the Regulatory Authorities concerning the Transfer review process and timing of such review process and approval of the various filings, and that such meetings will take place ahead of initiating the Transfer. Each of Schering and Millennium shall use, and Millennium shall procure that the New Commercial Licensee uses, commercially reasonable efforts to complete the Transfer of Regulatory Approvals for INTEGRILIN Products in each country in the Transferring Territory where Schering holds such Regulatory Approvals as soon as practicable after the Closing Date. The Parties acknowledge and agree that Millennium or New Commercial Licensee, as applicable, will have final decision making with regard to the plans, actions, filings and timing thereof required to complete the Transfer subject to the requirement that such decisions shall not delay the Marketing Authorization Transfer filings for the Territory [**] beyond the Closing Date. Commercially reasonable efforts by Schering pursuant to this Section 5.1(b) shall include, without limitation, promptly performing any actions reasonably necessary to effect the Transfer of all Regulatory Approvals existing as of the Effective Date in the Transferring Territory to Millennium or the New Commercial Licensee pursuant to this 5.1(b) i...
Transfer of Regulatory Approvals. Upon termination of this Agreement by Ampio under Section 13.2, Daewoong shall, and shall cause its Affiliates and any Terminated Sublicensees to, upon Ampio’s request, transfer to Ampio and/or its Affiliates and/or any Third Party appointed by Ampio (hereinafter referred to as “Transferee”) with reasonable assistance, excluding financial assistance, to the extent permissible under the Laws of the Territory, the Regulatory Approvals which Daewoong or its Affiliates or Terminated Sublicensees have with respect to the Products in the Territory, in each case subject to all licenses granted by any of them (whether or not in effect) to any Surviving Sublicensees and further subject to the royalty obligations (if any) set forth in Section 14.2. Such assistance shall include, among others, an authorization by Daewoong or its Affiliates or Terminated Sublicensees given to the Transferee to access to the Regulatory Approvals filed by Daewoong or its Affiliates or Terminated Sublicensees with the Regulatory Authorities with respect to the Products in the Territory (e.g., Regulatory Filings), the provision by Daewoong, if necessary, to the Transferee of the Daewoong Know-How and such other acts which the Transferee may reasonably request Daewoong in order to transfer such Regulatory Approvals with respect to the Products in the Territory, subject in all cases to such licenses held by the Surviving Sublicensees.
Transfer of Regulatory Approvals. On or as promptly as practical after the Closing, Seller shall deliver the Regulatory Documentation to Buyer and Buyer shall confirm receipt thereof, Within seven (7) Business Days Seller shall file the Seller FDA Letter with the FDA and shall provide notice to Buyer of such filing. Within seven (7) Business Days after receiving notice from the Seller of the filing of the Seller FDA Letter, Buyer shall file the Buyer FDA Letter with the FDA. Seller and Buyer shall take all other actions reasonably necessary to notify the FDA that the Regulatory Approvals have been transferred from Seller to Buyer and to affect the transfer of such Regulatory Approvals from Seller to Buyer.
Transfer of Regulatory Approvals. Upon termination of the Term of this Agreement in any country in the Territory for any reason, all right, title and interest in and to any Marketing Authorizations that are held by Merck, its Affiliates or assigns in such country shall automatically revert to Kos, and to the extent otherwise required, shall be promptly transferred to Kos. Kos shall be responsible for all fees payable to Regulatory Authorities relating to the transfer of such Marketing Authorizations to Kos. Such transfers shall be initiated within 30 days of any such termination and Merck shall use its reasonably diligent efforts to cause the timely completion of such transfers.
Transfer of Regulatory Approvals. In connection with the -------------------------------- consummation of the transactions contemplated by this Agreement, Sellers agree to transfer or cause their Affiliates to transfer all transferable Permits related to the operation of the Business to Purchaser in a timely fashion and Sellers shall use all commercially reasonable efforts both prior to and after Closing to complete such transfers as promptly as possible.
Transfer of Regulatory Approvals. On the Closing Date, the Seller shall transfer to the Purchaser or its designee the Regulatory Approvals set forth in SCHEDULE 2.2(E) hereto. Following such transfer, the Purchaser shall be solely responsible for obtaining all Regulatory Approvals regarding the
Transfer of Regulatory Approvals. According to the process or procedures recommended or required by the relevant Regulatory Authority, Seller shall initiate transfer, effective as of the Closing, of ownership or holdership of EUAs issued by FDA, foreign equivalents or similar Regulatory Approvals issued by Health Canada, and any Regulatory Approval issued by the TGA, including those listed in Schedule 9.14.
Transfer of Regulatory Approvals. Promptly after receipt of Regulatory Approval for the Vivelle-Dot(TM) Product in the Netherlands, the parties will work together to transfer such Regulatory Approvals to Novartis at Novartis' expense.
Transfer of Regulatory Approvals for the First-Gen COVID Vaccine Products. Upon the effective date of Option Exercise, CureVac shall (or shall cause the Affiliate or Third Party holding the Regulatory Approvals to) assign and transfer to GSK the Regulatory Approvals granted for the First-Gen COVID Vaccine Products, subject to GSK’s diligence obligations under Section 4.10 and the rights granted to CureVac with respect to the Regulatory Approvals relevant for the CureVac Territory under Section 6 and the respective Distribution Agreement. Any costs incurred in connection with this transfer shall be borne by the Parties in equal shares as part of the Development Costs in accordance with Section 4.3.
